Profile
Ann Lenich Hards worked as an Associate Director of Regulatory Affairs at Somatix Therapy Corp.
from 1995 to 1996.
She then worked as the Executive Vice President of Regulatory Affairs at ARCA biopharma, Inc. from 1996 to 2006.
During this time, she also worked as the VP of Cardiovascular & Thrombosis Regulatory at Sanofi-Aventis, Inc. from 1996 to 2006.
From 2011 to 2015, she worked as the EVP of Regulatory Affairs & Quality Assurance at Cleveland BioLabs, Inc. She also worked as the President of Pharmaceutical Development at Bridging Health-Matters, LLC from 2008 to 2010 and as the EVP of Regulatory Affairs at Statera Biopharma, Inc. She received her undergraduate degree from Purdue University and her doctorate from the University of Colorado Health Sciences Center.
Former positions of Ann Lenich Hards
| Companies | Position | End |
|---|---|---|
Bridging Health-Matters, LLC
 Bridging Health-Matters, LLC Medical/Nursing ServicesHealth Services Bridging Health-Matters, LLC provides healthcare services. The private company is based in Aurora. | Corporate Officer/Principal | 30/11/2010 |
ARCA biopharma, Inc. /Old/
 ARCA biopharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology ARCA biopharma, Inc. develops genetic therapies for heart failure and cardiovascular diseases. It offers Gencaro product, is an investigational pharmacologically unique beta-blocker and mild vasodilator being developed for heart failure and other indications. The company was founded by Michael R. Bristow and is headquartered in Denver, CO. | General Counsel | 31/12/2005 |
Sanofi-Aventis, Inc.
 Sanofi-Aventis, Inc. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sanofi-Aventis, Inc. is a company that manufactures and wholesales pharmaceutical products. The company is based in Scottsdale, AZ. | Corporate Officer/Principal | 31/12/2005 |
Somatix Therapy Corp.
 Somatix Therapy Corp. BiotechnologyHealth Technology Somatix Therapy Corp. researches, develops, and commercialize proprietary processes for the genetic modification of cells and their use in the treatment of human disease. Somatix's assets include its highly efficient gene transfer technology, broad-based intellectual property, and focused product development programs. The company's most advanced clinical development program, the GVAX cancer vaccine, is in Phase I/II clinical trials for the treatment of metastatic renal cell carcinoma, advanced melanoma, and prostate cancer. It is located in Alameda, CA | General Counsel | 30/04/1996 |
| STATERA BIOPHARMA, INC. | General Counsel | - |
Training of Ann Lenich Hards
| Purdue University | Undergraduate Degree |
| University of Colorado Health Sciences Center | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| STATERA BIOPHARMA, INC. | Health Technology |
| Private companies | 6 |
|---|---|
Somatix Therapy Corp.
Somatix Therapy Corp. BiotechnologyHealth Technology Somatix Therapy Corp. researches, develops, and commercialize proprietary processes for the genetic modification of cells and their use in the treatment of human disease. Somatix's assets include its highly efficient gene transfer technology, broad-based intellectual property, and focused product development programs. The company's most advanced clinical development program, the GVAX cancer vaccine, is in Phase I/II clinical trials for the treatment of metastatic renal cell carcinoma, advanced melanoma, and prostate cancer. It is located in Alameda, CA | Health Technology |
Cleveland BioLabs, Inc.
 Cleveland BioLabs, Inc. Pharmaceuticals: MajorHealth Technology Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome. It offers Entolimod, Mobilan, CBL0137, and SA-702. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Buffalo, NY. | Health Technology |
ARCA biopharma, Inc. /Old/
ARCA biopharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology ARCA biopharma, Inc. develops genetic therapies for heart failure and cardiovascular diseases. It offers Gencaro product, is an investigational pharmacologically unique beta-blocker and mild vasodilator being developed for heart failure and other indications. The company was founded by Michael R. Bristow and is headquartered in Denver, CO. | Health Technology |
| Pharmacia, Inc. | |
Sanofi-Aventis, Inc.
Sanofi-Aventis, Inc. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sanofi-Aventis, Inc. is a company that manufactures and wholesales pharmaceutical products. The company is based in Scottsdale, AZ. | Health Technology |
Bridging Health-Matters, LLC
Bridging Health-Matters, LLC Medical/Nursing ServicesHealth Services Bridging Health-Matters, LLC provides healthcare services. The private company is based in Aurora. | Health Services |
- Stock Market
- Insiders
- Ann Lenich Hards
